This announcement is a separate document:
浙江圣达生物药业股份有限公司关于2023年度向特定对象发行A股股票摊薄即期回报与填补措施及相关主体承诺（修订稿）的公告
Announcement of Zhejiang Shengda Biopharmaceutical Co., Ltd. on the issuance of A shares to specific targets in 2023, diluted immediate returns and compensation measures and related subjects' commitments (revised draft)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.